Y-mabs therapeutics, inc. (YMAB)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Dec'17
Assets
CURRENT ASSETS
Cash and cash equivalents

185,800

207,100

98,200

120,200

134,245

147,840

163,292

90,483

Restricted cash

-

-

-

-

30

31

31

32

Other current assets

4,062

4,819

1,399

3,027

2,759

3,661

2,721

840

Total current assets

189,836

211,955

99,591

123,190

137,034

151,532

166,044

91,355

Property and equipment, net

1,992

2,052

1,689

390

400

205

162

-

Operating lease right-of-use assets

1,865

1,989

2,086

2,216

2,320

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

772

Other assets

381

370

318

244

243

187

188

-

TOTAL ASSETS

194,074

216,366

103,684

126,040

139,997

151,924

166,394

92,127

LIABILITIES AND STOCKHOLDERS' EQUITY
LIABILITIES
Accounts payable

10,260

8,520

7,628

8,911

5,907

5,872

6,827

5,909

Accrued liabilities

4,035

4,550

5,848

4,215

3,877

3,251

2,489

2,016

Operating lease liabilities, current portion

548

516

516

502

517

-

-

-

Total current liabilities

14,843

13,586

13,992

13,628

10,301

9,123

9,316

7,925

Accrued milestone and royalty payments

1,901

1,921

1,932

2,050

2,050

2,050

2,050

2,050

Operating lease liabilities, long-term portion

1,543

1,714

1,821

1,980

2,133

-

-

-

Other liabilities

457

242

-

-

-

224

-

-

TOTAL LIABILITIES

18,744

17,463

17,745

17,658

14,484

11,397

11,366

9,975

Commitments and contingencies (Note 6)

-

-

-

-

-

-

0

0

STOCKHOLDERS? EQUITY
Preferred stock, $0.0001 par value, 5,500,000 shares authorized at March 31, 2020 and December 31, 2019; none issued at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

Common stock, $0.0001 par value, 100,000,000 shares authorized at March 31, 2020 and December 31, 2019; 39,757,623 and 39,728,416 shares issued at March 31, 2020 and December 31, 2019, respectively

4

4

3

3

3

3

3

3

Additional paid in capital

367,293

364,712

228,532

227,187

226,216

225,352

225,848

123,879

Accumulated other comprehensive income

75

50

131

-3

63

7

-48

-169

Accumulated deficit

-192,000

-165,900

-142,700

-118,800

-100,769

-84,835

-70,775

-41,561

TOTAL STOCKHOLDERS' EQUITY

175,330

198,903

85,939

108,382

125,513

140,527

155,028

82,152

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

194,074

216,366

103,684

126,040

139,997

151,924

166,394

92,127